Journal article
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
Abstract
BACKGROUND: Older adults with acute myeloid leukemia (AML) represent a vulnerable population in whom disease-based and clinical risk factors, patient goals, prognosis, and practitioner- and patient-perceived treatment risks and benefits influence treatment recommendations.
OBJECTIVE: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in …
Authors
Sekeres MA; Guyatt G; Abel G; Alibhai S; Altman JK; Buckstein R; Choe H; Desai P; Erba H; Hourigan CS
Journal
Blood Advances, Vol. 4, No. 15, pp. 3528–3549
Publisher
American Society of Hematology
Publication Date
August 11, 2020
DOI
10.1182/bloodadvances.2020001920
ISSN
2473-9529